125 results on '"Dupuy, Jean-William"'
Search Results
102. Development of a method for the extraction and analysis of grape skin proteins strongly bound to cell walls
- Author
-
Pasquier, Grégory, primary, Lapaillerie, Delphine, additional, Dupuy, Jean-William, additional, Lomenech, Anne-Marie, additional, Claverol, Stéphane, additional, Bonneu, Marc, additional, Geny, Laurence, additional, Teissedre, Pierre-Louis, additional, and Donèche, Bernard, additional
- Published
- 2013
- Full Text
- View/download PDF
103. Copper stress-induced changes in leaf soluble proteome of Cu-sensitive and tolerant Agrostis capillaris L. populations.
- Author
-
Hego, Elena, Vilain, Sébastien, Barré, Aurélien, Claverol, Stéphane, Dupuy, Jean‐William, Lalanne, Céline, Bonneu, Marc, Plomion, Christophe, and Mench, Michel
- Published
- 2016
- Full Text
- View/download PDF
104. Impact of foliar symptoms of “Esca proper” on proteins related to defense and oxidative stress of grape skins during ripening
- Author
-
Pasquier, Grégory, primary, Lapaillerie, Delphine, additional, Vilain, Sébastien, additional, Dupuy, Jean‐William, additional, Lomenech, Anne‐Marie, additional, Claverol, Stéphane, additional, Gény, Laurence, additional, Bonneu, Marc, additional, Teissedre, Pierre‐Louis, additional, and Donèche, Bernard, additional
- Published
- 2013
- Full Text
- View/download PDF
105. A Natural Antioxidant Pine Bark Extract, Oligopin®, Regulates the Stress Chaperone HSPB1 in Human Skeletal Muscle Cells: A Proteomics Approach
- Author
-
Poussard, Sylvie, primary, Pires-Alves, Amélie, additional, Diallo, Ramata, additional, Dupuy, Jean-William, additional, and Dargelos, Elise, additional
- Published
- 2012
- Full Text
- View/download PDF
106. An intersubunit disulfide bridge stabilizes the tetrameric nucleoside diphosphate kinase of Aquifex aeolicus
- Author
-
Boissier, Fanny, primary, Georgescauld, Florian, additional, Moynié, Lucile, additional, Dupuy, Jean-William, additional, Sarger, Claude, additional, Podar, Mircea, additional, Lascu, Ioan, additional, Giraud, Marie-France, additional, and Dautant, Alain, additional
- Published
- 2012
- Full Text
- View/download PDF
107. YPR139c/LOA1encodes a novel lysophosphatidic acid acyltransferase associated with lipid droplets and involved in TAG homeostasis
- Author
-
Ayciriex, Sophie, primary, Le Guédard, Marina, additional, Camougrand, Nadine, additional, Velours, Gisèle, additional, Schoene, Mario, additional, Leon, Sebastien, additional, Wattelet-Boyer, Valerie, additional, Dupuy, Jean-William, additional, Shevchenko, Andrej, additional, Schmitter, Jean-Marie, additional, Lessire, René, additional, Bessoule, Jean-Jacques, additional, and Testet, Eric, additional
- Published
- 2012
- Full Text
- View/download PDF
108. Proteomic analysis of proteins secreted by Botrytis cinerea in response to heavy metal toxicity
- Author
-
Cherrad, Semcheddine, primary, Girard, Vincent, additional, Dieryckx, Cindy, additional, Gonçalves, Isabelle R., additional, Dupuy, Jean-William, additional, Bonneu, Marc, additional, Rascle, Christine, additional, Job, Claudette, additional, Job, Dominique, additional, Vacher, Sébastien, additional, and Poussereau, Nathalie, additional
- Published
- 2012
- Full Text
- View/download PDF
109. Proteomic plasticity of two Eucalyptus genotypes under contrasted water regimes in the field
- Author
-
BEDON, FRANK, primary, VILLAR, EMILIE, additional, VINCENT, DELPHINE, additional, DUPUY, JEAN-WILLIAM, additional, LOMENECH, ANNE-MARIE, additional, MABIALANGOMA, ANDRÉ, additional, CHAUMEIL, PHILIPPE, additional, BARRÉ, AURÉLIEN, additional, PLOMION, CHRISTOPHE, additional, and GION, JEAN-MARC, additional
- Published
- 2011
- Full Text
- View/download PDF
110. Functional impact of PTP1B-mediated Src regulation on oxidative phosphorylation in rat brain mitochondria
- Author
-
Hébert Chatelain, Etienne, primary, Dupuy, Jean-William, additional, Letellier, Thierry, additional, and Dachary-Prigent, Jeanne, additional
- Published
- 2010
- Full Text
- View/download PDF
111. YPR139c/LOA1 encodes a novel lysophosphatidic acid acyltransferase associated with lipid droplets and involved in TAG homeostasis
- Author
-
Ayciriex, Sophie, Le Guédard, Marina, Camougrand, Nadine, Velours, Gisèle, Schoene, Mario, Leone, Sebastien, Wattelet-Boyer, Valerie, Dupuy, Jean-William, Shevchenko, Andrej, Schmitter, Jean-Marie, Lessire, René, Bessoule, Jean-Jacques, and Testet, Eric
- Abstract
For many years, lipid droplets (LDs) were considered to be an inert store of lipids. However, recent data showed that LDs are dynamic organelles playing an important role in storage and mobilization of neutral lipids. In this paper, we report the characterization of LOA1 (alias VPS66, alias YPR139c), a yeast member of the glycerolipid acyltransferase family. LOA1 mutants show abnormalities in LD morphology. As previously reported, cells lacking LOA1 contain more LDs. Conversely, we showed that overexpression results in fewer LDs. We then compared the lipidome of loa1Δ mutant and wild-type strains. Steady-state metabolic labeling of loa1Δ revealed a significant reduction in triacylglycerol content, while phospholipid (PL) composition remained unchanged. Interestingly, lipidomic analysis indicates that both PLs and glycerolipids are qualitatively affected by the mutation, suggesting that Loa1p is a lysophosphatidic acid acyltransferase (LPA AT) with a preference for oleoyl-CoA. This hypothesis was tested by in vitro assays using both membranes of Escherichia coli cells expressing LOA1 and purified proteins as enzyme sources. Our results from purification of subcellular compartments and proteomic studies show that Loa1p is associated with LD and active in this compartment. Loa1p is therefore a novel LPA AT and plays a role in LD formation.
- Published
- 2012
112. miR‐4510 blocks hepatocellular carcinoma development through RAF1 targeting and RAS/RAF/MEK/ERK signalling inactivation
- Author
-
Anne-Aurélie Raymond, Justine Charpentier, Jean-William Dupuy, Flora Cartier, Paulette Bioulac-Sage, Amani Ghousein, Christophe Grosset, Nicola Mosca, Biothérapies des maladies génétiques et cancers, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Génomique Fonctionnelle Bordeaux [Bordeaux] (CGFB), Institut Polytechnique de Bordeaux-Université de Bordeaux Ségalen [Bordeaux 2], Physiopathologie du cancer du foie, BaRITOn - Bordeaux Research in Translational Oncology, Université de Bordeaux Ségalen [Bordeaux 2], This study was supported by grants from L’Association pour le Développement du Liban to AG, La Ligue Régionale Contre le Cancer (Comités Dordogne, Comité Gironde) to AG and CFG, the French State in the framework of the ‘Investments for the future’ Programme IdEx Bordeaux (grant ANR‐10‐IDEX‐03‐02) to NM and La region Nouvelle‐Aquitaine to NM., ANR-10-IDEX-0003-02/10-IDEX-0003,IDEX BORDEAUX,IdEx Bordeaux(2010), Ghousein, Amani, Mosca, Nicola, Cartier, Flora, Charpentier, Justine, Dupuy, Jean-William, Raymond, Anne-Aurélie, Bioulac-Sage, Paulette, Grosset, Christophe F, Grosset, Christophe, Initiative d'excellence de l'Université de Bordeaux - - IDEX BORDEAUX2010 - ANR-10-IDEX-0003 - IDEX - VALID, and ANR-10-IDEX-0003,IDEX BORDEAUX,Initiative d'excellence de l'Université de Bordeaux(2010)
- Subjects
Sorafenib ,MAPK/ERK pathway ,Carcinoma, Hepatocellular ,MAP Kinase Signaling System ,Down-Regulation ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,liver ,Proto-Oncogene Mas ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Glypicans ,[SDV.CAN] Life Sciences [q-bio]/Cancer ,Cell Line, Tumor ,Regorafenib ,[SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology ,medicine ,Animals ,Humans ,[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology ,RAF1 ,Extracellular Signal-Regulated MAP Kinases ,Protein kinase A ,Wnt Signaling Pathway ,Cell Proliferation ,miR-4510 ,Messenger RNA ,Hepatology ,Oncogene ,Chemistry ,Cell growth ,Liver Neoplasms ,Wnt signaling pathway ,hepatocellular carcinoma ,RAS/RAF/MEK/ERK signalling ,Xenograft Model Antitumor Assays ,digestive system diseases ,3. Good health ,Gene Expression Regulation, Neoplastic ,Proto-Oncogene Proteins c-raf ,MicroRNAs ,030220 oncology & carcinogenesis ,Cancer research ,030211 gastroenterology & hepatology ,Chickens ,Signal Transduction ,medicine.drug - Abstract
International audience; BACKGROUND:Therapeutic outcomes using the multikinase inhibitors, sorafenib and regorafenib, remain unsatisfactory for patients with advanced hepatocellular carcinoma (HCC). Thus, new drug modalities are needed. We recently reported the remarkable capacity of miR-4510 to impede the growth of HCC and hepatoblastoma through Glypican-3 (GPC3) targeting and Wnt pathway inactivation.METHODS:To identify new targets of miR-4510, we used a label-free proteomic approach and reported down-regulation of RAF proto-oncogene serine/threonine-protein kinase (RAF1) by miR-4510. Because the tumourigenic role of RAF1 in HCC is controversial, we further studied RAF1:miR-4510 interactions using cellular, molecular as well as functional approaches and a chicken chorioallantoic membrane (CAM) xenograft model.RESULTS:We found an increase in RAF1 protein in 59.3% of HCC patients and a specific up-regulation of its transcript in proliferative tumours. We showed that miR-4510 inactivates the RAS/RAF/MEK/ERK pathway and reduces the expression of downstream targets (ie c-Fos proto-oncogene [FOS]) through RAF1 direct targeting. At a cellular level, miR-4510 inhibited HCC cell proliferation and migration and induced senescence in part by lowering RAF1 messenger RNA (mRNA) and protein expression. Finally, we confirmed the pro-tumoural function of RAF1 protein in HCC cells and its ability to sustain HCC tumour progression in vitro and in vivo.CONCLUSIONS:In this work, we confirm that RAF1 acts as an oncogene in HCC and further demonstrate that miR-4510 acts as a strong tumour suppressor in the liver by targeting many proto-oncogenes, including GPC3 and RAF1, and subsequently controlling key biological and signalling pathways among which Wnt and RAS/RAF/MEK/ERK signals.
- Published
- 2019
- Full Text
- View/download PDF
113. SAT045 - The role of RIPK3 in non-alcoholic fatty liver disease: a multi-omics perspective.
- Author
-
Mateus-Pinheiro, Miguel, Afonso, Marta B., Rodrigues, Pedro Miguel, Simão, André L., Gaspar, Maria Manuela, Di-Tommaso, Sylvaine, Raymond, Anne-Aurélie, Dupuy, Jean-William, Saltel, Frederic, Castro, Rui E., and Rodrigues, Cecília M.P.
- Subjects
- *
FATTY liver - Published
- 2020
- Full Text
- View/download PDF
114. Repression of apelin Furin cleavage sites provides antimetastatic strategy in colorectal cancer.
- Author
-
Demoures B, Soulet F, Descarpentrie J, Galeano-Otero I, Sanchez Collado J, Casado M, Smani T, González A, Alves I, Lalloué F, Masri B, Rascol E, Dupuy JW, Dourthe C, Saltel F, Raymond AA, Badiola I, Evrard S, Villoutreix B, Pernot S, Siegfried G, and Khatib AM
- Abstract
The adipokine apelin has been directly implicated in various physiological processes during embryogenesis and human cancers. Nevertheless, the importance of the conversion of its precursor proapelin to mature apelin in tumorigenesis remains unknown. In this study, we identify Furin as the cellular proprotein convertase responsible for proapelin cleavage. We explore the therapeutic potential of targeting proapelin cleavage sites in metastatic colorectal cancer by introducing apelin-dm, a modified variant resulting from alteration in proapelin cleavage sites. Apelin-dm demonstrates efficacy in inhibiting tumor growth, promoting cell death, suppressing angiogenesis, and early colorectal liver metastasis events. Proteomic analysis reveals reciprocal regulation between apelin and apelin-dm on proteins associated with clinical outcomes in colon cancer patients. Apelin-dm emerges as a modulator of apelin receptor dynamics, influencing affinity, internalization, and repression of apelin signaling linked to various protein kinases. Pharmacokinetic and toxicity assessments confirm the specificity, safety, and stability of apelin-dm, as well as its facile hepatic metabolism. These findings position targeting proapelin cleavage as a promising therapeutic strategy against metastatic colorectal cancer, paving the way for further clinical exploration., Competing Interests: Disclosure and competing interests statement. The authors declare no competing interests., (© 2025. The Author(s).)
- Published
- 2025
- Full Text
- View/download PDF
115. 3D bioprinted breast cancer model reveals stroma-mediated modulation of extracellular matrix and radiosensitivity.
- Author
-
Desigaux T, Comperat L, Dusserre N, Stachowicz ML, Lea M, Dupuy JW, Vial A, Molinari M, Fricain JC, Paris F, and Oliveira H
- Abstract
Deciphering breast cancer treatment resistance remains hindered by the lack of models that can successfully capture the four-dimensional dynamics of the tumor microenvironment. Here, we show that microextrusion bioprinting can reproducibly generate distinct cancer and stromal compartments integrating cells relevant to human pathology. Our findings unveil the functional maturation of this millimeter-sized model, showcasing the development of a hypoxic cancer core and an increased surface proliferation. Maturation was also driven by the presence of cancer-associated fibroblasts (CAF) that induced elevated microvascular-like structures complexity. Such modulation was concomitant to extracellular matrix remodeling, with high levels of collagen and matricellular proteins deposition by CAF, simultaneously increasing tumor stiffness and recapitulating breast cancer fibrotic development. Importantly, our bioprinted model faithfully reproduced response to treatment, further modulated by CAF. Notably, CAF played a protective role for cancer cells against radiotherapy, facilitating increased paracrine communications. This model holds promise as a platform to decipher interactions within the microenvironment and evaluate stroma-targeted drugs in a context relevant to human pathology., Competing Interests: All authors declare that there is no conflict of interest., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF
116. Loss of RND3/RHOE controls entosis through LAMP1 expression in hepatocellular carcinoma.
- Author
-
Basbous S, Dif L, Dantzer C, Di-Tommaso S, Dupuy JW, Bioulac-Sage P, Raymond AA, Desdouets C, Saltel F, and Moreau V
- Subjects
- Humans, Entosis, Proteomics, Transcription Factors, rho GTP-Binding Proteins, Lysosomal-Associated Membrane Protein 1, Carcinoma, Hepatocellular genetics, Liver Neoplasms genetics
- Abstract
Entosis is a process that leads to the formation of cell-in-cell structures commonly found in cancers. Here, we identified entosis in hepatocellular carcinoma and the loss of Rnd3 (also known as RhoE) as an efficient inducer of this mechanism. We characterized the different stages and the molecular regulators of entosis induced after Rnd3 silencing. We demonstrated that this process depends on the RhoA/ROCK pathway, but not on E-cadherin. The proteomic profiling of entotic cells allowed us to identify LAMP1 as a protein upregulated by Rnd3 silencing and implicated not only in the degradation final stage of entosis, but also in the full mechanism. Moreover, we found a positive correlation between the presence of entotic cells and the metastatic potential of tumors in human patient samples. Altogether, these data suggest the involvement of entosis in liver tumor progression and highlight a new perspective for entosis analysis in medicine research as a novel therapeutic target., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
117. iPS-cell-derived microglia promote brain organoid maturation via cholesterol transfer.
- Author
-
Park DS, Kozaki T, Tiwari SK, Moreira M, Khalilnezhad A, Torta F, Olivié N, Thiam CH, Liani O, Silvin A, Phoo WW, Gao L, Triebl A, Tham WK, Gonçalves L, Kong WT, Raman S, Zhang XM, Dunsmore G, Dutertre CA, Lee S, Ong JM, Balachander A, Khalilnezhad S, Lum J, Duan K, Lim ZM, Tan L, Low I, Utami KH, Yeo XY, Di Tommaso S, Dupuy JW, Varga B, Karadottir RT, Madathummal MC, Bonne I, Malleret B, Binte ZY, Wei Da N, Tan Y, Wong WJ, Zhang J, Chen J, Sobota RM, Howland SW, Ng LG, Saltel F, Castel D, Grill J, Minard V, Albani S, Chan JKY, Thion MS, Jung SY, Wenk MR, Pouladi MA, Pasqualini C, Angeli V, Cexus ONF, and Ginhoux F
- Subjects
- Animals, Humans, Mice, Cell Differentiation, Axons, Cell Proliferation, Esters metabolism, Lipid Droplets metabolism, Brain cytology, Brain metabolism, Induced Pluripotent Stem Cells cytology, Microglia cytology, Microglia metabolism, Neurogenesis, Organoids cytology, Organoids metabolism, Cholesterol metabolism, Neural Stem Cells cytology, Neural Stem Cells metabolism
- Abstract
Microglia are specialized brain-resident macrophages that arise from primitive macrophages colonizing the embryonic brain
1 . Microglia contribute to multiple aspects of brain development, but their precise roles in the early human brain remain poorly understood owing to limited access to relevant tissues2-6 . The generation of brain organoids from human induced pluripotent stem cells recapitulates some key features of human embryonic brain development7-10 . However, current approaches do not incorporate microglia or address their role in organoid maturation11-21 . Here we generated microglia-sufficient brain organoids by coculturing brain organoids with primitive-like macrophages generated from the same human induced pluripotent stem cells (iMac)22 . In organoid cocultures, iMac differentiated into cells with microglia-like phenotypes and functions (iMicro) and modulated neuronal progenitor cell (NPC) differentiation, limiting NPC proliferation and promoting axonogenesis. Mechanistically, iMicro contained high levels of PLIN2+ lipid droplets that exported cholesterol and its esters, which were taken up by NPCs in the organoids. We also detected PLIN2+ lipid droplet-loaded microglia in mouse and human embryonic brains. Overall, our approach substantially advances current human brain organoid approaches by incorporating microglial cells, as illustrated by the discovery of a key pathway of lipid-mediated crosstalk between microglia and NPCs that leads to improved neurogenesis., (© 2023. The Author(s), under exclusive licence to Springer Nature Limited.)- Published
- 2023
- Full Text
- View/download PDF
118. Spatial characterisation of β-catenin-mutated hepatocellular adenoma subtypes by proteomic profiling of the tumour rim.
- Author
-
Di Tommaso S, Dourthe C, Dupuy JW, Dugot-Senant N, Cappellen D, Cazier H, Paradis V, Blanc JF, Le Bail B, Balabaud C, Bioulac-Sage P, Saltel F, and Raymond AA
- Abstract
Background & Aims: Hepatocellular adenomas (HCAs) are rare, benign, liver tumours classified at the clinicopathological, genetic, and proteomic levels. The β-catenin-activated (b-HCA) subtypes harbour several mutation types in the β-catenin gene ( CTNNB1 ) associated with different risks of malignant transformation or bleeding. Glutamine synthetase is a surrogate marker of β-catenin pathway activation associated with the risk of malignant transformation. Recently, we revealed an overexpression of glutamine synthetase in the rims of exon 3 S45-mutated b-HCA and exon 7/8-mutated b-HCA compared with the rest of the tumour. A difference in vascularisation was found in this rim shown by diffuse CD34 staining only at the tumour centre. Here, we aimed to characterise this tumour heterogeneity to better understand its physiopathological involvement., Methods: Using mass spectrometry imaging, genetic, and proteomic analyses combined with laser capture microdissection, we compared the tumour centre with the tumour rim and with adjacent non-tumoural tissue., Results: The tumour rim harboured the same mutation as the tumour centre, meaning both parts belong to the same tumour. Mass spectrometry imaging showed different spectral profiles between the rim and the tumour centre. Proteomic profiling revealed the significant differential expression of 40 proteins at the rim compared with the tumour centre. The majority of these proteins were associated with metabolism, with an expression profile comparable with a normal perivenous hepatocyte expression profile., Conclusions: The difference in phenotype between the tumour centres and tumour rims of exon 3 S45-mutated b-HCA and exon 7/8-mutated b-HCA does not depend on CTNNB1 mutational status. In a context of sinusoidal arterial pathology, tumour heterogeneity at the rim harbours perivenous characteristics and could be caused by a functional peripheral venous drainage., Impact and Implications: Tumour heterogeneity was revealed in β-catenin-mutated hepatocellular adenomas (b-HCAs) via the differential expression of glutamine synthase at tumour rims. The combination of several spatial approaches (mass spectrometry imaging, genetic, and proteomic analyses) after laser capture microdissection allowed identification of a potential role for peripheral venous drainage underlying this difference. Through this study, we were able to illustrate that beyond a mutational context, many factors can downstream regulate gene expression and contribute to different clinicopathological phenotypes. We believe that the combinations of spatial analyses that we used could be inspiring for all researchers wanting to access heterogeneity information of liver tumours., Competing Interests: The authors declare that they have no conflicts of interest. Please refer to the accompanying ICMJE disclosure forms for further details., (© 2023 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
119. Short-range interactions between fibrocytes and CD8 + T cells in COPD bronchial inflammatory response.
- Author
-
Eyraud E, Maurat E, Sac-Epée JM, Henrot P, Zysman M, Esteves P, Trian T, Dupuy JW, Leipold A, Saliba AE, Begueret H, Girodet PO, Thumerel M, Hustache-Castaing R, Marthan R, Levet F, Vallois P, Contin-Bordes C, Berger P, and Dupin I
- Subjects
- Humans, Bronchi pathology, Epithelial Cells pathology, Inflammation pathology, CD8-Positive T-Lymphocytes, Pulmonary Disease, Chronic Obstructive
- Abstract
Bronchi of chronic obstructive pulmonary disease (COPD) are the site of extensive cell infiltration, allowing persistent contact between resident cells and immune cells. Tissue fibrocytes interaction with CD8
+ T cells and its consequences were investigated using a combination of in situ , in vitro experiments and mathematical modeling. We show that fibrocytes and CD8+ T cells are found in the vicinity of distal airways and that potential interactions are more frequent in tissues from COPD patients compared to those of control subjects. Increased proximity and clusterization between CD8+ T cells and fibrocytes are associated with altered lung function. Tissular CD8+ T cells from COPD patients promote fibrocyte chemotaxis via the CXCL8-CXCR1/2 axis. Live imaging shows that CD8+ T cells establish short-term interactions with fibrocytes, that trigger CD8+ T cell proliferation in a CD54- and CD86-dependent manner, pro-inflammatory cytokines production, CD8+ T cell cytotoxic activity against bronchial epithelial cells and fibrocyte immunomodulatory properties. We defined a computational model describing these intercellular interactions and calibrated the parameters based on our experimental measurements. We show the model's ability to reproduce histological ex vivo characteristics, and observe an important contribution of fibrocyte-mediated CD8+ T cell proliferation in COPD development. Using the model to test therapeutic scenarios, we predict a recovery time of several years, and the failure of targeting chemotaxis or interacting processes. Altogether, our study reveals that local interactions between fibrocytes and CD8+ T cells could jeopardize the balance between protective immunity and chronic inflammation in the bronchi of COPD patients., Competing Interests: EE, EM, JS, PH, PE, TT, JD, AL, AS, HB, MT, RH, RM, FL, PV, CC No competing interests declared, MZ MZ reports personal fees from AstraZeneca, Boehringer Ingelheim, Novartis, Chiesi, GlaxoSmithKline and non-financial support Lilly outside the submitted work, PG POG has a patent (EP 3050574: Use of plerixafor for treating and/or preventing acute exacerbations of chronic obstructive pulmonary disease) granted. POG reports grants, personal fees and non-financial support from AstraZeneca, personal fees and non-financial support from Chiesi, personal fees and non-financial support from GlaxoSmithKline, personal fees and non-financial support from Novartis, personal fees and non-financial support from Sanofi, outside the submitted work, PB PB has a patent (EP N3050574: Use of plerixafor for treating and/or preventing acute exacerbations of chronic obstructive pulmonary disease) granted. PB reports grants from AstraZeneca, Glaxo-Smith-Kline, Novartis, Chiesi, which support COBRA during the conduct of the study; grants and personal fees from AstraZeneca, BoehringerIngelheim, Novartis, personal fees and non-financial support from Chiesi, Sanofi, Menarini, outside the submitted work, ID ID has a patent (EP 3050574: Use of plerixafor for treating and/or preventing acute exacerbations of chronic obstructive pulmonary disease) granted, (© 2023, Eyraud et al.)- Published
- 2023
- Full Text
- View/download PDF
120. The E3 ubiquitin ligase FBXL6 controls the quality of newly synthesized mitochondrial ribosomal proteins.
- Author
-
Lavie J, Lalou C, Mahfouf W, Dupuy JW, Lacaule A, Cywinska AA, Lacombe D, Duchêne AM, Raymond AA, Rezvani HR, Ngondo RP, and Bénard G
- Subjects
- Mammals metabolism, Mitochondria metabolism, Mitochondrial Proteins metabolism, Protein Domains, Humans, Ribosomal Proteins metabolism, Ubiquitin-Protein Ligases metabolism
- Abstract
In mammals, about 99% of mitochondrial proteins are synthesized in the cytosol as precursors that are subsequently imported into the organelle. The mitochondrial health and functions rely on an accurate quality control of these imported proteins. Here, we show that the E3 ubiquitin ligase F box/leucine-rich-repeat protein 6 (FBXL6) regulates the quality of cytosolically translated mitochondrial proteins. Indeed, we found that FBXL6 substrates are newly synthesized mitochondrial ribosomal proteins. This E3 binds to chaperones involved in the folding and trafficking of newly synthesized peptide and to ribosomal-associated quality control proteins. Deletion of these interacting partners is sufficient to hamper interactions between FBXL6 and its substrate. Furthermore, we show that cells lacking FBXL6 fail to degrade specifically mistranslated mitochondrial ribosomal proteins. Finally, showing the role of FBXL6-dependent mechanism, FBXL6-knockout (KO) cells display mitochondrial ribosomal protein aggregations, altered mitochondrial metabolism, and inhibited cell cycle in oxidative conditions., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
121. A multi-adenylate cyclase regulator at the flagellar tip controls African trypanosome transmission.
- Author
-
Bachmaier S, Giacomelli G, Calvo-Alvarez E, Vieira LR, Van Den Abbeele J, Aristodemou A, Lorentzen E, Gould MK, Brennand A, Dupuy JW, Forné I, Imhof A, Bramkamp M, Salmon D, Rotureau B, and Boshart M
- Subjects
- Adenylyl Cyclases metabolism, Animals, Cyclic AMP, Trypanosoma, Trypanosoma brucei brucei metabolism, Tsetse Flies parasitology
- Abstract
Signaling from ciliary microdomains controls developmental processes in metazoans. Trypanosome transmission requires development and migration in the tsetse vector alimentary tract. Flagellar cAMP signaling has been linked to parasite social motility (SoMo) in vitro, yet uncovering control of directed migration in fly organs is challenging. Here we show that the composition of an adenylate cyclase (AC) complex in the flagellar tip microdomain is essential for tsetse salivary gland (SG) colonization and SoMo. Cyclic AMP response protein 3 (CARP3) binds and regulates multiple AC isoforms. CARP3 tip localization depends on the cytoskeletal protein FLAM8. Re-localization of CARP3 away from the tip microdomain is sufficient to abolish SoMo and fly SG colonization. Since intrinsic development is normal in carp3 and flam8 knock-out parasites, AC complex-mediated tip signaling specifically controls parasite migration and thereby transmission. Participation of several developmentally regulated receptor-type AC isoforms may indicate the complexity of the in vivo signals perceived., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
122. Discoidin Domain Receptor 2 orchestrates melanoma resistance combining phenotype switching and proliferation.
- Author
-
Sala M, Allain N, Moreau M, Jabouille A, Henriet E, Abou-Hammoud A, Uguen A, Di-Tommaso S, Dourthe C, Raymond AA, Dupuy JW, Gerard E, Dugot-Senant N, Rousseau B, Merlio JP, Pham-Ledart A, Vergier B, Tartare-Deckert S, Moreau V, and Saltel F
- Subjects
- Cell Line, Tumor, Cell Proliferation genetics, Drug Resistance, Neoplasm genetics, Humans, Phenotype, Protein Kinase Inhibitors pharmacology, Proto-Oncogene Proteins B-raf, Discoidin Domain Receptor 2 genetics, Melanoma drug therapy, Melanoma genetics, Melanoma metabolism
- Abstract
Combined therapy with anti-BRAF plus anti-MEK is currently used as first-line treatment of patients with metastatic melanomas harboring the somatic BRAF V600E mutation. However, the main issue with targeted therapy is the acquisition of tumor cell resistance. In a majority of resistant melanoma cells, the resistant process consists in epithelial-to-mesenchymal transition (EMT). This process called phenotype switching makes melanoma cells more invasive. Its signature is characterized by MITF low, AXL high, and actin cytoskeleton reorganization through RhoA activation. In parallel of this phenotype switching phase, the resistant cells exhibit an anarchic cell proliferation due to hyper-activation of the MAP kinase pathway. We show that a majority of human melanoma overexpress discoidin domain receptor 2 (DDR2) after treatment. The same result was found in resistant cell lines presenting phenotype switching compared to the corresponding sensitive cell lines. We demonstrate that DDR2 inhibition induces a decrease in AXL expression and reduces stress fiber formation in resistant melanoma cell lines. In this phenotype switching context, we report that DDR2 control cell and tumor proliferation through the MAP kinase pathway in resistant cells in vitro and in vivo. Therefore, inhibition of DDR2 could be a new and promising strategy for countering this resistance mechanism., (© 2022. The Author(s), under exclusive licence to Springer Nature Limited.)
- Published
- 2022
- Full Text
- View/download PDF
123. Asthmatic bronchial smooth muscle increases rhinovirus replication within the bronchial epithelium.
- Author
-
Esteves P, Allard B, Celle A, Dupin I, Maurat E, Ousova O, Thumerel M, Dupuy JW, Leste-Lasserre T, Marthan R, Girodet PO, Trian T, and Berger P
- Subjects
- Bronchi, Epithelium metabolism, Humans, Muscle, Smooth metabolism, Asthma metabolism, Rhinovirus
- Abstract
Rhinovirus (RV) infection of the bronchial epithelium is implicated in the vast majority of severe asthma exacerbations. Interestingly, the susceptibility of bronchial epithelium to RV infection is increased in persons with asthma. Bronchial smooth muscle (BSM) remodeling is an important feature of severe asthma pathophysiology, and its reduction using bronchial thermoplasty has been associated with a significant decrease in the exacerbation rate. We hypothesized that asthmatic BSM can play a role in RV infection of the bronchial epithelium. Using an original co-culture model between bronchial epithelium and BSM cells, we show that asthmatic BSM cells increase RV replication in bronchial epithelium following RV infection. These findings are related to the increased production of CCL20 by asthmatic BSM cells. Moreover, we demonstrate an original downregulation of the activity of the epithelial protein kinase RNA-activated (PKR) antiviral pathway. Finally, we identify a direct bottom-up effect of asthmatic BSM cells on bronchial epithelium susceptibility to RV infection., Competing Interests: Declaration of interests, (Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
124. Modulation of the ATM/autophagy pathway by a G-quadruplex ligand tips the balance between senescence and apoptosis in cancer cells.
- Author
-
Beauvarlet J, Bensadoun P, Darbo E, Labrunie G, Rousseau B, Richard E, Draskovic I, Londono-Vallejo A, Dupuy JW, Nath Das R, Guédin A, Robert G, Orange F, Croce S, Valesco V, Soubeyran P, Ryan KM, Mergny JL, and Djavaheri-Mergny M
- Subjects
- A549 Cells, Animals, Apoptosis genetics, Autophagy genetics, Cell Line, Tumor, Cellular Senescence genetics, DNA Damage drug effects, HeLa Cells, Humans, Ligands, Male, Mice, Mice, Inbred NOD, Mice, Knockout, Mice, SCID, Neoplasms genetics, Signal Transduction drug effects, Signal Transduction genetics, Xenograft Model Antitumor Assays, Apoptosis drug effects, Ataxia Telangiectasia Mutated Proteins antagonists & inhibitors, Ataxia Telangiectasia Mutated Proteins metabolism, Autophagy drug effects, Cellular Senescence drug effects, G-Quadruplexes, Neoplasms pathology
- Abstract
G-quadruplex ligands exert their antiproliferative effects through telomere-dependent and telomere-independent mechanisms, but the inter-relationships among autophagy, cell growth arrest and cell death induced by these ligands remain largely unexplored. Here, we demonstrate that the G-quadruplex ligand 20A causes growth arrest of cancer cells in culture and in a HeLa cell xenografted mouse model. This response is associated with the induction of senescence and apoptosis. Transcriptomic analysis of 20A treated cells reveals a significant functional enrichment of biological pathways related to growth arrest, DNA damage response and the lysosomal pathway. 20A elicits global DNA damage but not telomeric damage and activates the ATM and autophagy pathways. Loss of ATM following 20A treatment inhibits both autophagy and senescence and sensitizes cells to death. Moreover, disruption of autophagy by deletion of two essential autophagy genes ATG5 and ATG7 leads to failure of CHK1 activation by 20A and subsequently increased cell death. Our results, therefore, identify the activation of ATM by 20A as a critical player in the balance between senescence and apoptosis and autophagy as one of the key mediators of such regulation. Thus, targeting the ATM/autophagy pathway might be a promising strategy to achieve the maximal anticancer effect of this compound., (© The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.)
- Published
- 2019
- Full Text
- View/download PDF
125. The pH regulator PacC: a host-dependent virulence factor in Botrytis cinerea.
- Author
-
Rascle C, Dieryckx C, Dupuy JW, Muszkieta L, Souibgui E, Droux M, Bruel C, Girard V, and Poussereau N
- Subjects
- Botrytis growth & development, Botrytis metabolism, Cell Wall metabolism, Fungal Proteins genetics, Gene Deletion, Gene Expression Regulation, Fungal, Host Specificity, Hydrogen-Ion Concentration, Mycelium growth & development, Oxalic Acid metabolism, Oxidative Stress, Proteomics, Reactive Oxygen Species metabolism, Signal Transduction genetics, Virulence Factors genetics, Botrytis pathogenicity, Botrytis physiology, Fungal Proteins metabolism, Plant Diseases microbiology, Plants microbiology, Virulence genetics, Virulence Factors metabolism
- Abstract
The phytopathogenic fungus Botrytis cinerea is able to infect a wide variety of plants and plant tissues with differing chemical compositions. During its interaction with the host, this pathogen modulates its ambient pH by secreting acids or ammonia. In this work, we examined the Pal/Pac pathway, the fungal ambient pH-responsive signalling circuit, and investigated the role of the PacC transcription factor. Characterization of the BcpacC deletion mutant revealed an alteration of both fungal growth and virulence depending on the pH of the culture medium or of the host tissue. The pathogenicity of the mutant was altered on plants exhibiting a neutral pH and not on plants with acidic tissues. The capacity of the mutant to acidify its environment and, more particularly, to produce oxalic acid was affected, as was production of reactive oxygen species. Finally, proteomic profiling of the mutant secretome revealed significant changes in plant cell wall polysaccharides proteins and lipid degradation and oxidoreduction, highlighting the importance of BcPacC in the necrotrophic lifestyle of B. cinerea., (© 2018 Society for Applied Microbiology and John Wiley & Sons Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.